"Together with the international public and fans of Ms. Iga Swiatek, we are saddened by the situation that has occurred to the world's best tennis player. We are deeply moved by Ms. Iga Swiatek's statement dated November 28 2024, not only as employees of the pharmaceutical company, but also as fans of the Polish sports."
"We are truly sorry that the incident occurred involving the drug Melatonina LEK-AM 1 mg - all the more so because our drug has for many years been appreciated and trusted by doctors and patients, including professional athletes."
"LEK-AM Pharmaceutical Company has been manufacturing drugs of the highest quality and is regularly inspected by the Chief Pharmaceutical Inspectorate (GIF). We fulfill all the highest standards of drug manufacturing."
"We follow all procedures related to the production of pharmaceuticals, in accordance with the principles of Good Manufacturing Practice (GMP) regulated by EU and national law. Melatonina LEK-AM 1 mg is subject to strict inspection at every stage of production."
"Traces of impurities detected in the tested packages of the drug are well below the acceptable standard, which means that they do not threaten the health and life of patients to any extent. Melatonina LEK-AM 1 mg melatonin is safe for patients."
"Regarding the situation, LEK-AM is in constant dialogue with the Chief Pharmaceutical Inspectorate. We declare our full cooperation in order to clarify any doubts."
"We kindly inform that ITIA did not contact us directly. We were contacted by a law firm from the UK which, however, did not indicate for whom it works. The representative of the law firm expected us to violate the Polish pharmaceutical law [Art. 36 g (1) (10) of the Pharmaceutical Law Act, Journal of Laws 2024.686] especially with regard to sending medications to unauthorized persons."
"This rasied our distrust and the lack of our response. From today's perspective, we would have initiated contact."
Loading